Data / Form D filings / Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.: Form D filing
Galmed Pharmaceuticals Ltd., a pharmaceuticals company in Tel Aviv, Israel, filed a Form D with the SEC in 2017. The latest, on August 15, 2017, reports $100,000 sold of a $350,000 offering to 1 investor.
Find out what Galmed Pharmaceuticals Ltd. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 16 TIOMKIN STREET, Tel Aviv, Israel, 65783
- Phone
- 972 3 693 8448
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Israel
- Year incorporated
- 2013
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1595353
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 15, 2017 | New notice | $350,000 | $100,000 | $250,000 | 1 | Aug 9, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ran Oren | Director | |
| Tali Gorfine | Executive Officer | |
| Carol Brosgart | Director | |
| David Sidransky | Director | |
| Yohai Stenzler | Executive Officer | |
| Liat Hayardeny | Executive Officer | |
| Shmuel Nir | Director | |
| William Marth | Director | |
| Allen Baharaff | Executive Officer, Director | |
| Chaim Hurvitz | Director | |
| Tali Yaron-Eldar | Director |
Every Form D from the week of Aug 14, 2017 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Galmed Pharmaceuticals Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.